Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2006-01-10
2006-01-10
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C514S506000, C514S767000, C514S768000, C554S078000, C554S079000, C554S080000, C554S081000, C554S085000, C564S341000
Reexamination Certificate
active
06984396
ABSTRACT:
Conjugates of a hydrophobic moiety, such as a lipid, linked through a cleavable dithiobenzyl linkage to a therapeutic agent are described. The dithiobenzyl linkage is susceptible to cleavage by mild thiolysis, resulting in release of the therapeutic agent in its original form. The linkage is stable under nonreducing conditions. The conjugate can be incorporated into liposomes for administration in vivo and release of the therapeutic agent in response to endogeneous in vivo reducing conditions or in response to administration of an exogeneous reducing agent.
REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4766106 (1988-08-01), Katre et al.
patent: 4902502 (1990-02-01), Nitecki et al.
patent: 4917888 (1990-04-01), Katre et al.
patent: 4935465 (1990-06-01), Garman
patent: 5103556 (1992-04-01), Filip et al.
patent: 5169934 (1992-12-01), Clark et al.
patent: 5395619 (1995-03-01), Zalipsky et al.
patent: 5631018 (1997-05-01), Zalipsky et al.
patent: 5891468 (1999-04-01), Martin et al.
patent: 0 317 956 (1989-05-01), None
patent: 0 317 957 (1989-05-01), None
patent: 0 510 197 (1992-10-01), None
patent: 2 254 336 (1975-07-01), None
patent: 1113391 (1989-05-01), None
patent: WO 97/36904 (1997-10-01), None
patent: 98/16201 (1998-04-01), None
patent: WO 99/29302 (1999-06-01), None
Brois, S.J., et al.,J. Amer. Chem. Soc. 92(26):7629-7631 (1970).
Dittmer, J.C., et al.,J. Lipid Res.126-127 (1964).
Grice, R., et al.,J. Chem. Soc. 1947-1954 (1963).
Kaneko, T., et al.,Bioconjugate Chem. 2(3):133-141 (1991).
Lash, L.H., et al.,Arch. Biochem. Biophys. 240(2):583-592 (1985).
Veronese, et al.,Applied Biochem. And Biotech. 141-152 (1985).
Zalipsky, et al.,Biotechnol. Appl. Biochem. 100-114 (1992).
Zalipsky, et al.,Eur. Polymer. J. 19(12):1177-1183 (1983).
Zalipsky, et al.,Bioconj. Chem. 4(4):296-299 (1993).
Gaber, M., et al.,Pharmaceutical Res12(10):1407-1416, (1995).
Hirota, S.,International J of Pharmaceutics162(1-2):185-194, (1998).
Johnsson, M., et al.,J of Liposome Res9(1):53-79, (1999).
Kirpotin, D., et al.,FEBS Letters388:115-118, (1996).
Mueller, C.E., et al., 322(6):343-350, (1989).
Senter, P.D., et al.,J Org Chem55(9):2975-2978, (1990).
Vaage, J., et al.,Cancer72(12):3671-3675, (1993).
Vaage, J., et al.,Cancer73(5):1478-1484, (1994).
Vaage, J., et al.,International J of Cancer51(6)942-948, ().
Zalipsky,Bioconj Chem10(5):703-707, (1999).
International Journal of Cancer80(1):134-137, (1999).
Diaz, C., et al.,Bioconjugate Chem 9(2):250-254, (1998).
Waalkis in Selective Cancer Therapeutics, vol. 6, No. 1, 1990.
Asia in Biol. Pharm. Bull. vol. 21 (7), pp. 766-771, 1998.
Gabizon Alberto A.
Zalipsky Samuel
Alza Corporation
Kishore Gollamudi S.
LandOfFree
Conjugate having a cleavable linkage for use in a liposome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugate having a cleavable linkage for use in a liposome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugate having a cleavable linkage for use in a liposome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3574888